In addition, A2B5+/CD133+ and A2B5+/CD133− subpopulations from glioma were capable of forming neurospheres in vitro and initiating tumors in vivo, suggesting that A2B5 is a GSC marker [70]. Here, PROM1 is linked to central nervous system cancer.